SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-004044
Filing Date
2022-04-13
Accepted
2022-04-13 10:52:56
Documents
1
Period of Report
2022-04-11

Document Format Files

Seq Description Document Type Size
1 form4-04132022_070447.html 4  
1 form4-04132022_070447.xml 4 5875
  Complete submission text file 0001415889-22-004044.txt   7240
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYENOVIA INC 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address
JACOBSON RACHEL (Reporting) CIK: 0001911725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 22823983